Cargando…
The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men
Reduction in testosterone levels in men during aging is associated with cognitive decline and risk of dementia. Animal studies have shown benefits for testosterone supplementation in improving cognition and reducing Alzheimer’s disease pathology. In a randomized, placebo-controlled, crossover study...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078598/ https://www.ncbi.nlm.nih.gov/pubmed/26553159 http://dx.doi.org/10.2174/1871527315666151110125704 |
_version_ | 1782462412417400832 |
---|---|
author | Wahjoepramono, Eka J. Asih, Prita R. Aniwiyanti, Vilia Taddei, Kevin Dhaliwal, Satvinder S. Fuller, Stephanie J. Foster, Jonathan Carruthers, Malcolm Verdile, Giuseppe Sohrabi, Hamid R. Martins, Ralph N. |
author_facet | Wahjoepramono, Eka J. Asih, Prita R. Aniwiyanti, Vilia Taddei, Kevin Dhaliwal, Satvinder S. Fuller, Stephanie J. Foster, Jonathan Carruthers, Malcolm Verdile, Giuseppe Sohrabi, Hamid R. Martins, Ralph N. |
author_sort | Wahjoepramono, Eka J. |
collection | PubMed |
description | Reduction in testosterone levels in men during aging is associated with cognitive decline and risk of dementia. Animal studies have shown benefits for testosterone supplementation in improving cognition and reducing Alzheimer’s disease pathology. In a randomized, placebo-controlled, crossover study of men with subjective memory complaint and low testosterone levels, we investigated whether testosterone treatment significantly improved performance on various measures of cognitive functioning. Forty-four men were administered a battery of neuropsychological tests to establish the baseline prior to being randomly divided into two groups. The first group (Group A) received 24 weeks of testosterone treatment (T treatment) followed by 4 weeks washout, and then 24 weeks of placebo (P); the second group (Group B) received the same treatments, in reverse order (Placebo, washout, and then T treatment). In group A (TèP), compared to baseline, there was a modest (1 point) but significant improvement in general cognitive functioning as measured by the Mini Mental State Examination (MMSE) following testosterone treatment. This improvement from baseline was sustained following the washout period and crossover to placebo treatment. Similar Mini Mental State Examination (MMSE) scores were observed when comparing testosterone treatment with placebo. In group B (PèT) a significant increase was observed from baseline following testosterone treatment and a trend towards an increase when compared to placebo treatment. Improvements in baseline depression scores (assessed by Geriatric Depression Scale) were observed following testosterone/placebo treatment in both groups, and no difference was observed when comparing testosterone with placebo treatment. Our findings indicate a modest improvement on global cognition with testosterone treatment. Larger clinical trials with a longer follow- up and with the inclusion of blood and brain imaging markers are now needed to conclusively determine the significance of testosterone treatment. |
format | Online Article Text |
id | pubmed-5078598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-50785982016-11-14 The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men Wahjoepramono, Eka J. Asih, Prita R. Aniwiyanti, Vilia Taddei, Kevin Dhaliwal, Satvinder S. Fuller, Stephanie J. Foster, Jonathan Carruthers, Malcolm Verdile, Giuseppe Sohrabi, Hamid R. Martins, Ralph N. CNS Neurol Disord Drug Targets Article Reduction in testosterone levels in men during aging is associated with cognitive decline and risk of dementia. Animal studies have shown benefits for testosterone supplementation in improving cognition and reducing Alzheimer’s disease pathology. In a randomized, placebo-controlled, crossover study of men with subjective memory complaint and low testosterone levels, we investigated whether testosterone treatment significantly improved performance on various measures of cognitive functioning. Forty-four men were administered a battery of neuropsychological tests to establish the baseline prior to being randomly divided into two groups. The first group (Group A) received 24 weeks of testosterone treatment (T treatment) followed by 4 weeks washout, and then 24 weeks of placebo (P); the second group (Group B) received the same treatments, in reverse order (Placebo, washout, and then T treatment). In group A (TèP), compared to baseline, there was a modest (1 point) but significant improvement in general cognitive functioning as measured by the Mini Mental State Examination (MMSE) following testosterone treatment. This improvement from baseline was sustained following the washout period and crossover to placebo treatment. Similar Mini Mental State Examination (MMSE) scores were observed when comparing testosterone treatment with placebo. In group B (PèT) a significant increase was observed from baseline following testosterone treatment and a trend towards an increase when compared to placebo treatment. Improvements in baseline depression scores (assessed by Geriatric Depression Scale) were observed following testosterone/placebo treatment in both groups, and no difference was observed when comparing testosterone with placebo treatment. Our findings indicate a modest improvement on global cognition with testosterone treatment. Larger clinical trials with a longer follow- up and with the inclusion of blood and brain imaging markers are now needed to conclusively determine the significance of testosterone treatment. Bentham Science Publishers 2016-04 2016-04 /pmc/articles/PMC5078598/ /pubmed/26553159 http://dx.doi.org/10.2174/1871527315666151110125704 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Wahjoepramono, Eka J. Asih, Prita R. Aniwiyanti, Vilia Taddei, Kevin Dhaliwal, Satvinder S. Fuller, Stephanie J. Foster, Jonathan Carruthers, Malcolm Verdile, Giuseppe Sohrabi, Hamid R. Martins, Ralph N. The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men |
title | The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men |
title_full | The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men |
title_fullStr | The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men |
title_full_unstemmed | The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men |
title_short | The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men |
title_sort | effects of testosterone supplementation on cognitive functioning in older men |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078598/ https://www.ncbi.nlm.nih.gov/pubmed/26553159 http://dx.doi.org/10.2174/1871527315666151110125704 |
work_keys_str_mv | AT wahjoepramonoekaj theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT asihpritar theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT aniwiyantivilia theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT taddeikevin theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT dhaliwalsatvinders theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT fullerstephaniej theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT fosterjonathan theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT carruthersmalcolm theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT verdilegiuseppe theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT sohrabihamidr theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT martinsralphn theeffectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT wahjoepramonoekaj effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT asihpritar effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT aniwiyantivilia effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT taddeikevin effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT dhaliwalsatvinders effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT fullerstephaniej effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT fosterjonathan effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT carruthersmalcolm effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT verdilegiuseppe effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT sohrabihamidr effectsoftestosteronesupplementationoncognitivefunctioninginoldermen AT martinsralphn effectsoftestosteronesupplementationoncognitivefunctioninginoldermen |